1. Protein S-mediated signal transduction pathway regulates lung cancer cell proliferation, migration and angiogenesis
   Lutfi Suleiman et al, 2021, Hematology/Oncology and Stem Cell Therapy CrossRef
2. The vitamin K-dependent factor, protein S, regulates brain neural stem cell migration and phagocytic activities towards glioma cells
   Aurélie Ginisty et al, 2019, European Journal of Pharmacology CrossRef
3. Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma
   Songyun Zhao et al, 2023, BMC Medical Genomics CrossRef
4. Aberrant expression of PROS1 correlates with human papillary thyroid cancer progression
   Jing Wang et al, 2021, PeerJ CrossRef
5. LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification
   Yujie Zhou et al, 2022, Journal of Translational Medicine CrossRef
6. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology
   Bridget Shafit-Zagardo et al, 2018, Pharmacology & Therapeutics CrossRef
7. Dysregulation of Protein S in COVID-19
   Martha M.S. Sim et al, 2022, Best Practice & Research Clinical Haematology CrossRef
8. Immunological role of TAM receptors in the cancer microenvironment
   Varsha Gadiyar et al, 2020, TAM Receptors in Health and Disease CrossRef
9. Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas
   Filippos Anagnostakis et al, 2023, Current Neuropharmacology CrossRef
10. Regulation of bone homeostasis by MERTK and TYRO3
    Janik Engelmann et al, 2022, Nature Communications CrossRef
11. Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
    Yunxiang Zhou et al, 2021, Cell Communication and Signaling CrossRef
12. Silencing of ZFP36L2 increases sensitivity to temozolomide through G2/M cell cycle arrest and BAX mediated apoptosis in GBM cells
    Mohd Firdaus Che Mat et al, 2021, Molecular Biology Reports CrossRef
13. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients
    Songyun Zhao et al, 2023, Frontiers in Immunology CrossRef
14. The TAM family as a therapeutic target in combination with radiation therapy
    Francesco M. Marincola et al, 2017, Emerging Topics in Life Sciences CrossRef
15. Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment
    Jane Koo et al, 2020, Frontiers in Oncology CrossRef
16. Proteomics changes after negative pressure wound therapy in diabetic foot ulcers
    Zeguo Jia et al, 2021, Molecular Medicine Reports CrossRef
17. TAM receptors, Phosphatidylserine, inflammation, and Cancer
    Tal Burstyn-Cohen et al, 2019, Cell Communication and Signaling CrossRef
18. Tumor Cell Invasion in Glioblastoma
    Arabel Vollmann-Zwerenz et al, 2020, International Journal of Molecular Sciences CrossRef
19. Regulation of immune response against third-stage Gnathostoma spinigerum larvae by human genes
    Pattarasuda Puasri et al, 2023, Frontiers in Immunology CrossRef
20. CeRNA regulatory network-based analysis to study the roles of noncoding RNAs in the pathogenesis of intrahepatic cholangiocellular carcinoma
    Weiyu Xu et al, 2020, Aging CrossRef
21. TYRO3: A potential therapeutic target in cancer
    Pei-Ling Hsu et al, 2019, Experimental Biology and Medicine CrossRef
22. New insights into vitamin K biology with relevance to cancer
    JoEllen Welsh et al, 2022, Trends in Molecular Medicine CrossRef
23. PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: A bioinformatics analysis combined with experimental verification
    Tianyi He et al, 2023, Cellular Signalling CrossRef